NASDAQ:ALXN - Alexion Pharmaceuticals Price Target & Analyst Ratings

-5.41 (-4.09 %)
(As of 06/24/2019 04:00 PM ET)
Today's Range
Now: $126.98
50-Day Range
MA: $124.75
52-Week Range
Now: $126.98
Volume1.73 million shs
Average Volume1.52 million shs
Market Capitalization$28.47 billion
P/E Ratio17.91
Dividend YieldN/A

Analyst Ratings

Alexion Pharmaceuticals (NASDAQ:ALXN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. Their average twelve-month price target is $161.8824, suggesting that the stock has a possible upside of 27.49%. The high price target for ALXN is $188.00 and the low price target for ALXN is $123.00. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.762.762.802.89
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $161.8824$161.8824$162.6429$163.1176
Price Target Upside: 27.49% upside28.67% upside24.37% upside72.37% upside

Alexion Pharmaceuticals (NASDAQ:ALXN) Consensus Price Target History

Price Target History for Alexion Pharmaceuticals (NASDAQ:ALXN)

Alexion Pharmaceuticals (NASDAQ:ALXN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/23/2019CitigroupLower Price TargetBuy ➝ Buy$180.00 ➝ $165.00LowView Rating Details
5/23/2019Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$142.00LowView Rating Details
5/22/2019WedbushInitiated CoverageOutperform ➝ Outperform$173.00MediumView Rating Details
4/26/2019Raymond JamesBoost Price TargetOutperform ➝ Outperform$161.00 ➝ $164.00LowView Rating Details
3/27/2019Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$165.00 ➝ $186.00LowView Rating Details
3/21/2019GuggenheimReiterated RatingNeutral ➝ Neutral$135.00HighView Rating Details
3/13/2019CowenReiterated RatingBuy$165.00LowView Rating Details
2/12/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$165.00 ➝ $175.00HighView Rating Details
1/22/2019Credit Suisse GroupReiterated RatingBuy$156.00MediumView Rating Details
11/26/2018OppenheimerSet Price TargetBuy$165.00MediumView Rating Details
10/24/2018Leerink SwannSet Price TargetBuy$181.00HighView Rating Details
9/28/2018BarclaysBoost Price TargetPositive ➝ Overweight$175.00LowView Rating Details
9/25/2018Stifel NicolausBoost Price TargetHold ➝ Hold$130.00 ➝ $136.00LowView Rating Details
9/24/2018Robert W. BairdSet Price TargetBuy$165.00MediumView Rating Details
7/27/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$184.00 ➝ $188.00HighView Rating Details
7/27/2018Jefferies Financial GroupReiterated RatingHold$123.00HighView Rating Details
7/26/2018Evercore ISIReiterated RatingOutperform$158.00MediumView Rating Details
4/12/2018NomuraBoost Price TargetBuy$165.00LowView Rating Details
3/15/2018Deutsche BankSet Price TargetBuy$161.00HighView Rating Details
2/12/2018SunTrust BanksSet Price TargetBuy$172.00MediumView Rating Details
2/9/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$177.00 ➝ $180.00LowView Rating Details
1/4/2018UBS GroupDowngradeStrong-Buy ➝ OutperformMediumView Rating Details
10/23/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ Overweight$170.00N/AView Rating Details
(Data available from 6/24/2017 forward)
This page was last updated on 6/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel